KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nu Skin Enterprises (NUS) Common Equity (2016 - 2025)

Historic Common Equity for Nu Skin Enterprises (NUS) over the last 17 years, with Q3 2025 value amounting to $799.8 million.

  • Nu Skin Enterprises' Common Equity rose 1314.52% to $799.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $799.8 million, marking a year-over-year increase of 1314.52%. This contributed to the annual value of $651.5 million for FY2024, which is 2074.45% down from last year.
  • According to the latest figures from Q3 2025, Nu Skin Enterprises' Common Equity is $799.8 million, which was up 1314.52% from $787.8 million recorded in Q2 2025.
  • In the past 5 years, Nu Skin Enterprises' Common Equity registered a high of $941.0 million during Q2 2022, and its lowest value of $651.5 million during Q4 2024.
  • Its 5-year average for Common Equity is $835.9 million, with a median of $841.9 million in 2022.
  • As far as peak fluctuations go, Nu Skin Enterprises' Common Equity skyrocketed by 1588.54% in 2021, and later plummeted by 2336.32% in 2024.
  • Over the past 5 years, Nu Skin Enterprises' Common Equity (Quarter) stood at $912.8 million in 2021, then decreased by 1.7% to $897.3 million in 2022, then decreased by 8.4% to $822.0 million in 2023, then decreased by 20.74% to $651.5 million in 2024, then rose by 22.77% to $799.8 million in 2025.
  • Its Common Equity stands at $799.8 million for Q3 2025, versus $787.8 million for Q2 2025 and $754.0 million for Q1 2025.